(Q35577601)

9 August 2017

1 reference

title

Incretin-based medications for type 2 diabetes: an overview of reviews (English)

1 reference

9 August 2017

1 reference

1

J-M Gamble

1 reference

9 August 2017

A Clarke

2

1 reference

9 August 2017

K J Myers

3

1 reference

9 August 2017

M D Agnew

4

1 reference

9 August 2017

K Hatch

5

1 reference

9 August 2017

M M Snow

6

1 reference

9 August 2017

E M Davis

7

1 reference

9 August 2017

10 April 2015

1 reference

Diabetes, Obesity and Metabolism

9 August 2017

1 reference

9 August 2017

17

1 reference

9 August 2017

7

1 reference

9 August 2017

649-658

1 reference

Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.

9 August 2017

1 reference

Standards of medical care in diabetes--2014

21 January 2018

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

21 January 2018

1 reference

Therapy in the early stage: incretins

21 January 2018

1 reference

Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitors

21 January 2018

1 reference

Epidemiology and reporting characteristics of systematic reviews

21 January 2018

1 reference

Methodology in conducting a systematic review of systematic reviews of healthcare interventions

21 January 2018

1 reference

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

21 January 2018

1 reference

Early-life determinants of overweight and obesity: a review of systematic reviews

21 January 2018

1 reference

Quality assessment of systematic reviews or meta-analyses of nursing interventions conducted by Korean reviewers

21 January 2018

1 reference

Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings

21 January 2018

1 reference

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

21 January 2018

1 reference

Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

21 January 2018

1 reference

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.

21 January 2018

1 reference

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

21 January 2018

1 reference

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

Overlapping meta-analyses on the same topic: survey of published studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12465

1 reference

9 August 2017

1 reference